Danaher buying GE biopharma unit for $21.4B

General Electric Co. (NYSE:GE) agreed to sell its biopharma business for $21.4 billion in cash to Danaher

Read the full 177 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE